Top Anticoagulants Companies in the Global Market
20 May, 2025

The market for Anticoagulants is anticipated to grow at a compound annual growth rate (CAGR) of 8.97% from 2025 to 2033, from US$ 41.31 billion in 2024 to US$ 89.50 billion by 2033.

Anticoagulants, often known as blood thinners, are medications that prolong the clotting time by slowing or preventing blood from coagulating. They are crucial in the management of several heart diseases, including atrial fibrillation, pulmonary embolism (PE), stroke, and deep vein thrombosis (DVT). The worldwide anticoagulant market is influenced by a number of factors, including end-use industries, market data, government regulations, private and governmental investments, and significant industry events including mergers, acquisitions, partnerships, agreements, expansions, and inventions.

Likewise, the Europe Anticoagulants Market is projected to grow at a compound annual growth rate (CAGR) of 8.22% from 2025 to 2033, from US$ 11.63 billion in 2024 to US$ 23.68 billion by 2033.

Several well-known pharmaceutical firms dominate the worldwide anticoagulant industry in terms of innovation, market share, and global presence. These businesses treat diseases including atrial fibrillation, deep vein thrombosis, and pulmonary embolism with a variety of anticoagulant treatments, such as vitamin K antagonists, low molecular weight heparins (LMWH), and new oral anticoagulants (NOACs). Their substantial research and development work advances anticoagulant therapies and enhances patient outcomes globally.

Discover key trends, growth opportunities, and major challenges shaping the Anticoagulants Industry in Renub Research’s latest in-depth market report. Download your free sample now

Top Anticoagulants Companies in 2025: Leading Blood Thinner Manufacturers

Alexion Pharmaceuticals Inc.

Establishment: 1992

Headquarters: United States of America

Website: www.alexion.com

Revenue: $6.1B in 2020

AstraZeneca Plc's subsidiary Alexion Pharmaceuticals Inc. (Alexion) is a pharmaceutical business that finds, creates, and sells treatments for uncommon and serious illnesses. Products from the company include eculizumab for atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH), asfotase alfa for hypophosphatasia (HPP), ravulizumab-cwvz for PNH, danicopan for PNH, and sebelipase alfa for lysosomal acid lipase (LAL) deficiency; selumetinib for neurofibromatosis type 1 (NF1). Additionally, Alexion creates treatments for gMG, or generalized myasthenia gravis. The labels Kanuma, Koselugo, SOLIRIS, STRENSIQ, ULTOMIRIS, and Voydeya are used by Alexion to sell its goods. The business has operations throughout Asia Pacific, North America, Latin America, Europe, and the Middle East. The US city of Boston, Massachusetts, is home to Alexion's headquarters.

Aspen Holdings

Establishment: 1850

Headquarters: South Africa

Website: www.aspenpharma.com

Revenue: $2.4B in 2023

Athletic and sports lifestyle goods are designed, produced, and sold by adidas AG (adidas). The company's product line consists of clothing, shoes, and accessories including balls, backpacks, sunglasses, and exercise gear. Adidas distributes and sells its items through a number of channels, such as department shops, e-retailers, sports goods chains, own-branded stores, retail stores, wholesale stores, franchise stores, and buying groups. Additionally, it uses mobile shopping applications and e-commerce sites like adidas.co.in to market its goods. The adidas brand is used to sell its goods. The headquarters of adidas are located in Herzogenaurach, Bayern, Germany.

Bayer AG

Establishment: 1863

Headquarters: Germany

Website: www.bayer.com

Revenue: $50.4B in 2023

Bayer AG (Bayer) carries out the discovery, development, manufacturing, and commercialization of products for human health, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology, and other indications. It also strives to develop new molecules and technologies for use in the fields of medicine and modern agriculture. The company's product portfolio includes prescription products, specialty pharmaceuticals, diagnostic imaging equipment, non-prescription (over-the-counter or OTC) products, seeds, crop protection solutions and non-agricultural pest control solutions. Bayer markets its products through wholesalers, pharmacies, hospitals, and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East. Bayer is headquartered in Leverkusen, North Rhine-Westphalia, Germany.

Bristol-Myers Squibb Company

Establishment: 1887

Headquarters: United States of America

Website: www.bms.com

Revenue: $48.3B in 2023

The biopharmaceutical business Bristol-Myers Squibb Co. (BMS) is involved in the research, development, licensing, production, marketing, distribution, and retailing of novel biopharmaceutical drugs. The business sells its goods in therapeutic fields including neurology, immunology, cardiovascular disease, hematology, and cancer. In order to create certain medications, it also works with third parties through co-development, co-commercialization, licensing, or joint venture agreements. With brands including Opdivo, Reblozyl, Krazati, Sprycel, and Sotyktu, among others, BMS supplies wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government organizations. It has production facilities in the Netherlands, Puerto Rico, Ireland, Switzerland, and the United States. The US city of Princeton, New Jersey, is home to BMS's headquarters.

Daiichi Sankyo Company Limited

Establishment: 2005

Headquarters: Japan

Website: www.daiichisankyo.co.jp

Revenue: $13.1B in 2023

Global healthcare provider Daiichi Sankyo Co Ltd (Daiichi Sankyo) is dedicated to finding, creating, and providing cutting-edge medical solutions. The firm sells a variety of medications, including vaccinations, over-the-counter (OTC) medications, and prescription medications. Its product line includes medications for a variety of malignancies as well as neurological, nephrological, diabetic, metabolic, infectious, and cardiovascular disorders. The business also conducts research on immunological disorders and uncommon diseases in addition to cancer. Daiichi Sankyo uses a wide network of medical representatives in addition to its group firms to promote its goods. It operates in Europe, Asia, South and Central America, and North America. Tokyo, Japan, is home to Daiichi Sankyo's headquarters.

Dr. Reddy’s Laboratories Ltd

Establishment: 1984

Headquarters: India

Website: www.drreddys.com

Revenue: $3.4B in 2023

Dr. Reddy's Laboratories Ltd., also known as Dr. Reddy's, is a multinational pharmaceutical corporation. Active pharmaceutical ingredients (API), intermediates, and final pharmaceutical products—both prescription and over-the-counter—are the company's main business operations. The company's product line includes over-the-counter pharmaceuticals, biosimilars, branded generics, and generics. Numerous medical specialties, including gastrointestinal, cardiovascular disease, diabetes, cancer, pain management, and dermatology, employ the company's goods. Customers from all around the world may obtain reasonably priced and cutting-edge medications from Dr. Reddy's. New Chemical Entities (NCEs) that target the management of bacterial infections, inflammation, pain, and metabolic diseases are part of its pipeline. The corporation sells its goods throughout Asia, Latin America, Europe, and the United States. The headquarters of Dr. Reddy's are located in Hyderabad, Telangana, India.

GlaxoSmithKline plc

Establishment: 2000

Headquarters: United Kingdom

Website: www.gsk.com

Revenue: $40.1B in 2023

The healthcare business GSK plc (GSK) is dedicated to creating, producing, and marketing vaccines, specialty medications, and general medications. HIV, respiratory, cancer, immuno-inflammation, antiviral, central nervous system (CNS), metabolic, cardiovascular, and urogenital, antibacterial, dermatological, and uncommon disorders are among the illnesses it treats with medications. Additionally, the firm sells over-the-counter (OTC) medications for gastrointestinal disorders, pain management, nutrition, skin health, and dental health. Hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles, and bacterial meningitis are just a few of the illnesses that are covered by GSK's vaccine portfolio. The business offers its goods through pharmacies, hospitals, doctors, wholesalers, and other organizations all around the world. The headquarters of GSK are located in London, England, in the UK.

Johnson & Johnson Private Limited

Establishment: 1957

Headquarters: United States of America

Website: www.jnj.com

Revenue: $88.8B in 2023

Research, development, production, and distribution of cutting-edge medications and medical technology are the activities of Johnson & Johnson (J&J), a healthcare organization. The corporation uses its operational companies to carry out its activities. It offers medical equipment for use in the sectors of cardiovascular, orthopedic, neurovascular, general surgery, and vision care, as well as pharmaceutical items for treatment areas linked to immunological disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic illnesses. The business sells its goods to hospitals, wholesalers, medical experts, and retailers. It operates production operations throughout the US, Europe, Asia-Pacific, Africa, Western Hemisphere (excluding the US), and Latin America. The US city of New Brunswick, New Jersey, is home to J&J's headquarters.

Pfizer Inc.

Establishment: 1849

Headquarters: United States of America

Website: www.pfizer.com

Revenue: $63.6B in 2023

Pfizer Inc. is a biopharmaceutical firm that focuses on research. It finds, creates, produces, sells, and distributes medications and vaccines. Anti-infectives, cancer, cardiology, diabetes, obesity, inflammation, immunology, uncommon disorders, and bacterial infections are just a few of the therapeutic areas that the company's medicines address. Healthcare professionals, hospitals, clinics, and pharmacies utilize Pfizer's medicines to treat a range of illnesses. With names including Zavzpret, Abrysvo, Inflectra, Genotropin, Octagam, and Bosulif, among others, the corporation sells its goods through a network of wholesalers, merchants, and government organizations. Among other countries, it runs production facilities in Belgium, Germany, India, Ireland, Italy, Japan, Singapore, and the United States. The US city of New York is home to Pfizer's headquarters.

Sanofi

Establishment: 1973

Headquarters: France

Website: www.sanofi.com

Revenue: $47.9B in 2023

The healthcare business Sanofi is involved in the research, development, production, and distribution of a variety of medications and vaccines. Its product line includes vaccinations for humans to protect against a variety of bacterial and viral illnesses, medications to treat cancer, uncommon disorders, and multiple sclerosis, and other items. In addition, the firm sells consumer health goods for women's health, allergies, cough, cold, flu, and sinuses, pain, and vitamins, minerals, and supplements. Sanofi's research and development activities are concentrated on developing a combination medication to boost treatment efficacy and on developing novel biologics formulations to create precision medications. It operates in the Middle East, Asia-Pacific, Africa, the Americas, and Europe. The headquarters of Sanofi are located in Paris, France's Ile-de-France.